+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

From
From
Oncology Pharmaceuticals Market - Product Thumbnail Image

Oncology Pharmaceuticals Market

  • Report
  • October 2024
  • 181 Pages
  • Global
From
Pruritus Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Pruritus Therapeutics Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 190 Pages
  • Global
From
From
Gene Editing Therapeutics Market - Product Thumbnail Image

Gene Editing Therapeutics Market

  • Report
  • August 2024
  • 111 Pages
  • Global
From
Pulmonary Embolism Therapeutics Market 2025-2029 - Product Thumbnail Image

Pulmonary Embolism Therapeutics Market 2025-2029

  • Report
  • June 2025
  • 206 Pages
  • Global
From
From
From
Cardiovascular Therapeutics Market 2025-2029 - Product Thumbnail Image

Cardiovascular Therapeutics Market 2025-2029

  • Report
  • March 2025
  • 219 Pages
  • Global
From
Small Molecule Active Pharmaceutical Ingredient Market Report 2026 - Product Thumbnail Image

Small Molecule Active Pharmaceutical Ingredient Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Insomnia Drugs - Global Strategic Business Report - Product Thumbnail Image

Insomnia Drugs - Global Strategic Business Report

  • Report
  • May 2026
  • 189 Pages
  • Global
From
Facial Palsy - Global Strategic Business Report - Product Thumbnail Image

Facial Palsy - Global Strategic Business Report

  • Report
  • May 2026
  • 367 Pages
  • Global
From
Anticholinergic Drugs - Global Strategic Business Report - Product Thumbnail Image

Anticholinergic Drugs - Global Strategic Business Report

  • Report
  • May 2026
  • 276 Pages
  • Global
From
Neuralgia Treatment - Global Strategic Business Report - Product Thumbnail Image

Neuralgia Treatment - Global Strategic Business Report

  • Report
  • May 2026
  • 276 Pages
  • Global
From
Dry Age-related Macular Degeneration (Dry-AMD)- Pipeline Insight, 2025 - Product Thumbnail Image

Dry Age-related Macular Degeneration (Dry-AMD)- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Juvenile Macular Degeneration - Pipeline Insight, 2025 - Product Thumbnail Image

Juvenile Macular Degeneration - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Loading Indicator